Get access

Delay of Ejaculation Induced by SB-277011, a Selective Dopamine D3 Receptor Antagonist, in the Rat

Authors


Francois Giuliano, MD, Hôpital Raymond Poincaré, 104 boulevard Raymond Poincaré, 92380 Garches, France. Tel: +33-(0)147107832; Fax: +33-(0)147107615; E-mail: giuliano@cyber-sante.org

ABSTRACT

Introduction.  Dopamine (DA) plays a key role in different aspects of the male sexual response, including sexual motivation and arousal, penile erection, and ejaculation. The modalities of action of DA are however unclear, although the various DA receptors may differentially mediate the activity of DA in different aspects of the male sexual response.

Aim.  To clarify the role of DA D3 receptors in the control of the male sexual response.

Methods.  The effects of a highly selective DA D3 receptors antagonist (SB-277011; intraperitoneal) were tested in experimental paradigms exploring several aspects of the male sexual response in (i) anesthetized rats using 7-hydroxy-N,N-di-n-propylaminotetralin to induce ejaculation and (ii) conscious rats using sexual incentive motivation and mating tests.

Main Outcome Measures.  Physiological markers of erection and emission and expulsion phases of ejaculation were measured in anesthetized rats. Behavioral parameters of sexual incentive motivation and mating tests were quantified.

Results.  In anesthetized rats, we found that SB-277011 specifically and dose-dependently inhibited the expulsion phase of ejaculation without impairing either emission phase or erection, and this resulted in delayed ejaculation. Administration of SB-277011 had no effect on the spontaneous preference that males displayed for sexually receptive females as shown in sexual incentive motivation test. Delayed ejaculation was confirmed when male rats were administered with the highest dose of SB-277011 (10 mg/kg) in mating test, where males were free to copulate with estrous females. In addition, the refractory period following ejaculation was lengthened in rats treated with SB-277011.

Conclusion.  As a whole, the present data demonstrate the specific and primary role of D3 receptors in the expulsion phase of ejaculation and provide preclinical evidence for the investigation of the therapeutic potential of D3 antagonism for treating premature ejaculation. Clément P, Pozzato C, Heidbreder C, Alexandre L, Giuliano F, and Melotto S. Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat. J Sex Med **;**:**–**.

Ancillary